Elevated LPS has been shown to provoke metabolic endotoxemia, which in turn has been demonstrated to drive low-grade inflammation, insulin resistance, and adiposity (Breton et al., 2022). This evidence concerns the gene INS and serum lipopolysaccharide activity.